Vetoquinol's sales for FY 2024 came to ¬539 million, up 1.9 % on a reported basis and 2.2% at constant exchange rates. Exchange rates had a negative impact of -¬1.9 million.

Looking ahead to 2025, Quest Diagnostics projects revenue in the range of $10.70 billion to $10.85 billion, indicating continuous growth. The adjusted diluted EPS guidance stands between $9.55 and ...